Literature DB >> 8737255

Blood group glycosphingolipid expression in kidney of an individual with the rare blood group A1 Le(a-b+) p phenotype: absence of blood group structures based on the globoseries.

K Lindström1, P A Jovall, S Ghardashkani, B E Samuelsson, M E Breimer.   

Abstract

Total neutral glycolipid fractions were isolated from kidney and ureter tissue obtained at autopsy of an individual of the rare blood group A1 Le(a-b+) p. The amount of glycolipids isolated were 3.7 and 2.5 mg g-1 dry tissue weight for the kidney and ureter tissue, which is in the range of reference blood group P kidneys. Part of the kidney glycolipid fraction was subfractionated by HPLC. Glycolipid compounds were structurally characterized by thin-layer chromatography (chemical detection and immunostaining with monoclonal antibodies), proton NMR spectroscopy and mass spectrometry. Globotriaosyl- and globotetraosyl-ceramides, which are the major compounds in kidneys of P individuals, were absent in the p kidney, and a comparatively increased amount of monoglycosyl- and lactosylceramides was found. A shift to longer fatty acyl chains in the ceramide part of lactosylceramides was noted. Elongated globoseries compounds with five to seven sugar residues, including the blood group A type 4 chain structure, were lacking. A slight increase in neolactotetraosyl- and blood group X pentaglycosyl-ceramides was noticed. The study confirms an enzymatic block in the conversion of lactosylceramide to elongated globoseries compounds in the kidney tissue similar to that of erythrocytes of p individuals.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8737255     DOI: 10.1007/bf00731505

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  22 in total

1.  Glycosphingolipid expression in spontaneously aborted fetuses and placenta from blood group p women. Evidence for placenta being the primary target for anti-Tja-antibodies.

Authors:  K Lindström; A E Von Dem Borne; M E Breimer; B Cedergren; Y Okubo; L Rydberg; S Teneberg; B E Samuelsson
Journal:  Glycoconj J       Date:  1992-12       Impact factor: 2.916

2.  Monoclonal antibodies defining blood group A variants with difucosyl type 1 chain (ALeb) and difucosyl type 2 chain (ALey).

Authors:  H Clausen; J M McKibbin; S Hakomori
Journal:  Biochemistry       Date:  1985-10-22       Impact factor: 3.162

3.  A murine monoclonal IgM antibody specific for blood group P antigen (globoside)

Authors:  A E von dem Borne; M J Bos; N Joustra-Maas; J F Tromp; M B van't Veer; R van Wijngaarden-du Bois; P A Tetteroo
Journal:  Br J Haematol       Date:  1986-05       Impact factor: 6.998

4.  Further characterization of type 2 and type 3 chain blood group A glycosphingolipids from human erythrocyte membranes.

Authors:  H Clausen; S B Levery; E Nudelman; M Baldwin; S Hakomori
Journal:  Biochemistry       Date:  1986-11-04       Impact factor: 3.162

5.  Preparation of total nonacid glycolipids for overlay analysis of receptors for bacteria and viruses and for other studies.

Authors:  K A Karlsson
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

6.  Recent studies of glycolipid and glycoprotein profiles and characterization of the major glycolipid antigen in gastric cancer of a patient of blood group genotype pp (Tja-) first studied in 1951.

Authors:  R Kannagi; P Levine; K Watanabe; S Hakomori
Journal:  Cancer Res       Date:  1982-12       Impact factor: 12.701

7.  Blood group A glycolipid antigen expression in kidney, ureter, kidney artery, and kidney vein from a blood group A1Le(a-b+) human individual. Evidence for a novel blood group A heptaglycosylceramide based on a type 3 carbohydrate chain.

Authors:  J Holgersson; H Clausen; S Hakomori; B E Samuelsson; M E Breimer
Journal:  J Biol Chem       Date:  1990-12-05       Impact factor: 5.157

8.  Structural analysis of glycosphinoglipids by high-resolution 1H nuclear magnetic resonance spectroscopy.

Authors:  J Dabrowski; P Hanfland; H Egge
Journal:  Biochemistry       Date:  1980-11-25       Impact factor: 3.162

9.  Expression of glycolipid blood group antigens in single human kidneys: change in antigen expression of rejected ABO incompatible kidney grafts.

Authors:  A Ulfvin; A E Bäcker; H Clausen; S Hakomori; L Rydberg; B E Samuelsson; M E Breimer
Journal:  Kidney Int       Date:  1993-12       Impact factor: 10.612

10.  Abnormalities in the glycosphingolipid content of human Pk and p erythrocytes.

Authors:  D M Marcus; M Naiki; S K Kundu
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.